Bullish
Chardan initiates CAMP4 Therapeutics stock with buy rating
Chardan has initiated coverage on CAMP4 Therapeutics with a buy rating and a price target of $6.50, citing significant upside potential from its curre...
CAMP
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest CAMP News
Bullish
Research CAMP on:
Ad Space